↓ Skip to main content

Cochrane Database of Systematic Reviews

Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis

Overview of attention for article published in Cochrane database of systematic reviews, December 2013
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)

Mentioned by

twitter
4 tweeters

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
24 Mendeley
Title
Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis
Published in
Cochrane database of systematic reviews, December 2013
DOI 10.1002/14651858.cd009421.pub2
Pubmed ID
Authors

Saldanha IJ, Akinyede O, McKoy NA, Robinson KA

Abstract

For patients with cystic fibrosis and advanced pulmonary damage, lung transplantation is an available and viable option. However, graft rejection is an important potential consequence after lung transplantation. Immunosuppressive therapy is needed to prevent episodes of graft rejection and thus subsequently reduce morbidity and mortality in this population. There are a number of classes of immunosuppressive drugs which act on different components of the immune system. There is considerable variability in the use of immunosuppressive agents after lung transplantation in cystic fibrosis. While much of the research in immunosuppressive drug therapy has focused on the general population of lung transplant recipients, little is known about the comparative effectiveness and safety of these agents in patients with cystic fibrosis.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 4%
United States 1 4%
Unknown 22 92%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 25%
Student > Ph. D. Student 4 17%
Student > Bachelor 3 13%
Student > Doctoral Student 2 8%
Other 2 8%
Other 5 21%
Unknown 2 8%
Readers by discipline Count As %
Medicine and Dentistry 10 42%
Biochemistry, Genetics and Molecular Biology 2 8%
Economics, Econometrics and Finance 2 8%
Psychology 2 8%
Mathematics 1 4%
Other 3 13%
Unknown 4 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 February 2014.
All research outputs
#6,531,400
of 12,101,174 outputs
Outputs from Cochrane database of systematic reviews
#5,929
of 7,978 outputs
Outputs of similar age
#85,190
of 217,037 outputs
Outputs of similar age from Cochrane database of systematic reviews
#115
of 152 outputs
Altmetric has tracked 12,101,174 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,978 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.6. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 217,037 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 152 others from the same source and published within six weeks on either side of this one. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.